Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Vocal Cord Paralysis

ClinicalTrials.gov lists 57 trials for Vocal Cord Paralysis or a narrower condition beneath it. APrevent Biotech GmbH has the most among industry and government lead sponsors, with 2.

MeSH D014826 Respiratory Tract Diseases C08 C09 C10 C23
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 1 Phase 1/2 Phase 1/2 1 Phase 2 Phase 2 4 Phase 3 Phase 3 3 Phase 4 Phase 4 1 Not applicable Not applicable 32 Observational Observational 15 Phase 1 Phase 1 1 Phase 1/2 Phase 1/2 1 Phase 2 Phase 2 4 Phase 3 Phase 3 3 Phase 4 Phase 4 1 Not applicable Not applicable 32 Observational Observational 15

Trials per phase (log scale)

57 of the 57 trials are tagged with Vocal Cord Paralysis itself; the rest are tagged with a narrower condition beneath it.

Get the Vocal Cord Paralysis report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Vocal Cord Paralysis trials start? (23)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here.

Trials over time, by phase

  • Phase 1/2
  • Phase 2
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 7

2000: 1 trials (Not applicable 1) 2002: 1 trials (Phase 3 1) 2003: 1 trials (Phase 2 1) 2004: 1 trials (Not applicable 1) 2005: 1 trials (Not applicable 1) 2006: 2 trials (Observational 1, Not applicable 1) 2008: 1 trials (Observational 1) 2010: 1 trials (Phase 2 1) 2011: 3 trials (Observational 1, Not applicable 2) 2012: 1 trials (Phase 1/2 1) 2013: 1 trials (Observational 1) 2014: 3 trials (Observational 3) 2015: 2 trials (Observational 1, Not applicable 1) 2016: 3 trials (Observational 1, Not applicable 1, Phase 2 1) 2018: 5 trials (Not applicable 3, Phase 4 1, Phase 3 1) 2019: 7 trials (Observational 2, Not applicable 5) 2020: 5 trials (Observational 1, Not applicable 4) 2021: 1 trials (Observational 1) 2022: 3 trials (Not applicable 2, Phase 3 1) 2023: 2 trials (Not applicable 2) 2024: 3 trials (Observational 1, Not applicable 1, Phase 2 1) 2025: 4 trials (Observational 1, Not applicable 3)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 4
2025 4
2024 3
2023 2
2022 3
2021 1
2020 5
2019 7
2018 5
2016 3

No forecast is made for this condition: it averages 3.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Prediction, not a registry value: median of 36 months from start to primary completion across 7 trials still running at the 2026-10-09 snapshot; registered median of 22 months across 29 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Vocal Cord Paralysis trials in? (7)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 1
Phase 1/2 1
Phase 2 4
Phase 3 3
Phase 4 1
Not applicable 32
Observational 15

How many Vocal Cord Paralysis trials are recruiting? (8)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 6
Recruiting 4
Enrolling by invitation 1
Active, not recruiting 1
Completed 30

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Vocal Cord Paralysis trials? (1)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
APrevent Biotech GmbH 2

Interventions as named in the registry (7)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Corticoids 1
centrifuged autologous fat 1
Renuva Allograft Adipose Matrix 1
Sugamadex 1
Dexamethasone/Dexamethasone acetate 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which publications cover Vocal Cord Paralysis? (130)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Oral Corticosteroids in Vocal Fold Paralysis After Thyroid Surgery: A Randomized Clinical Trial. JAMA otolaryngology-- head & neck surgery 2025 Yes
Diagnostic Accuracy of Laryngeal Ultrasound for Evaluating Vocal Fold Movement Impairment in Children. Journal of pediatric surgery 2024 Yes
Voice outcome in medialisation thyroplasty with and without arytenoid adduction: a prospective comparison using intraoperative voice measurements. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2024 Yes
Dysphagia Outcomes Following Surgical Management of Unilateral Vocal Fold Immobility in Children: A Systematic Review. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2023 Yes
Clarifying optimal outcome measures in intermittent and continuous laryngeal neuromonitoring. Head & neck 2022 Yes

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.

Browse all condition evidence pages